A61P 27 - Drugs for disorders of the senses

Patents for A61P 27 - Drugs for disorders of the senses (53,017)
10/2009
10/13/2009	CA2472373C Combination of paclitaxel and a polymer
10/13/2009	CA2455298C Condensed polycyclic compounds
10/13/2009	CA2395866C Ophthalmic anti-allergy compositions suitable for use with contact lenses
10/13/2009	CA2386974C Benzodiazepine derivatives for use in acute or chronic neurological disorders
10/08/2009	WO2009123761A1 Beta-turn peptidomimetic cyclic compounds for treating dry eye
10/08/2009	WO2009123316A1 Heterocyclic derivative and use thereof
10/08/2009	WO2009123241A1 Inhibitor of plasminogen activator inhibitor-1
10/08/2009	WO2009123221A1 Pyrimidine derivative having cell-protecting activity and use thereof
10/08/2009	WO2009123099A1 Aqueous liquid containing gatifloxacin
10/08/2009	WO2009123098A1 Aqueous liquid containing gatifloxacin, method for production thereof, and method for prevention of production of precipitates during storage of the aqueous liquid at low temperature or upon freezing/thawing of the aqueous liquid
10/08/2009	WO2009122748A1 Therapeutic agent for respiratory diseases or allergic diseases
10/08/2009	WO2009122148A1 Fused thiophene and thiazole derivatives as pi3k kinase inhibitors
10/08/2009	WO2009121959A1 Use of glycosaminoglycan for restoring glycocalyx
10/08/2009	WO2009102715A3 Peptide therapy for ocular herpes infections
10/08/2009	WO2009089399A3 Compositions comprising toll-like receptor or coreceptor antagonists and methods for ocular neuroprotection
10/08/2009	US20090253807 Aqueous suspension preparations
10/08/2009	US20090253804 Method for treating or preventing dry eye disorders using alkylamino-polyhydroxyalkanes
10/08/2009	US20090253767 Aminoindazolylurea derivatives
10/08/2009	US20090253765 Angiogenesis Inhibitor Containing Amine Derivative as Active Ingredient
10/08/2009	US20090253745 Modulators of ocular oxidative stress
10/08/2009	US20090253683 7-membered ring compound and method of production and pharmaceutical application thereof
10/08/2009	US20090253645 Methods and materials for treating and preventing inflammation of mucosal tissue
10/08/2009	US20090253175 Use to faciliate drug delivery of other drugs, or treat glycosaminoglycan associated pathologies, such as scarring, spinal cord injury, glaucoma, and cosmetic treatments
10/08/2009	US20090252810 Aryl/alkyl Succinic Anhydride-Hyaluronan Derivatives
10/08/2009	US20090252752 Kdr peptides and vaccines comprising the same
10/08/2009	DE102008016998A1 Langsam lösliche quervernetzte Matrices zur Verabreichung von Proteinarzneistoffen Slowly soluble cross-linked matrices for the administration of protein drugs
10/08/2009	CA2720343A1 Heterocyclic derivative and use thereof
10/08/2009	CA2720141A1 Beta-turn peptidomimetic cyclic compounds for treating dry eye
10/08/2009	CA2720049A1 Pyrimidine derivative having cell protecting effect and uses thereof
10/08/2009	CA2718826A1 Gatifloxacin-containing aqueous liquid preparation
10/08/2009	CA2718641A1 Gatifloxacin-containing aqueous liquid preparation, its production and method for suppressing formation of precipitate during storage at lower temperature and at the time of freezing and thawing of the aqueous liquid preparation
10/07/2009	EP2107052A1 Novel n-(2-aminophenyl)benzamide derivative having an urea structure
10/07/2009	EP2107050A1 Lipoxin compounds
10/07/2009	EP1617216B1 Novel method of screening
10/07/2009	EP1529038B1 Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity
10/07/2009	EP1385550B1 Therapeutic medicaments for inducing tolerance
10/07/2009	EP1308441B1 2-aminopyridine compounds and use thereof as drugs
10/07/2009	CN101553235A Use of a steroid prodrug for the treatment of disease of the posterior segment of the eye
10/07/2009	CN101553214A Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy
10/07/2009	CN101553206A Water insoluble polymer matrix for drug delivery
10/07/2009	CN101550114A Thiazole derivatives having CB1-antagonistic, agonistic or partial agonistic activity
10/07/2009	CN101549160A Application of the sulfur-butyl ether-belta-cyclodextrin in eyedrops of chloramphenicol and method thereof
10/07/2009	CN101549159A Application of the hydroxypropyl-belta-cyclodextrin in eyedrops of chloramphenicol and method thereof
10/07/2009	CN101549118A Traditional Chinese medicine composition for treating red-eye disease and preparation method thereof
10/07/2009	CN101549067A Chinese medicinal composition and uses thereof
10/07/2009	CN101549026A Chinese medicine prescription for curing central exudative chorioretinopathy
10/07/2009	CN101548995A Application of Viscum album extract as NF-kB inhibitor
10/07/2009	CN101548962A Preparation method of lutein microcapsule
10/07/2009	CN100546977C New compounds for the inhibition of rotamases and use thereof
10/07/2009	CN100546610C Medicine and food dual purpose product for preventing myopia and its manufacturing method
10/07/2009	CN100546609C Use of composition in preparing medicine for preventing and treating cataract
10/07/2009	CN100546587C Medicine and food dual purpose compound vitamin and compound microelement nutritive product for preventing and treating xeroma and its manufacturing method
10/06/2009	US7598293 Antidiabetic agents, antilipemic agents, dietetics, anticholesterol agents, hypotensive agents, cardiovascular disorders; (S)-Ethyl 2-methoxy-3-[4-{3-(4-methanesulfonyloxyphenyl) propylamino}phenyl]propionate
10/06/2009	US7598288 Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma
10/06/2009	US7598277 cancer, inflammatory, autoimmune, infectious and viral diseases , destructive bone disorders, proliferative and neurodegenerative disorders; 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine
10/06/2009	US7598272 Kinase inhibitors
10/06/2009	US7598253 Reverse-turn mimetics and methods relating thereto
10/06/2009	US7598242 Compounds for the treatment of inflammatory disorders
10/01/2009	WO2009120881A1 Methods for improving lid margin and tear film function and treatment of lid margin desease using tetracycline family antibiotics
10/01/2009	WO2009120699A2 Antimicrobials having polyquarternary ammoniums and alcohol-bearing amidoamines and methods for their use
10/01/2009	WO2009120615A2 Substituted gamma lactams as therapeutic agents
10/01/2009	WO2009120300A2 Method of treating degenerative diseases
10/01/2009	WO2009119858A1 Benzene compound, and use thereof for medical purposes
10/01/2009	WO2009119534A1 Novel tetrahydroisoquinoline derivative
10/01/2009	WO2009100137A3 Magnetic cells for localizing delivery and tissue repair
10/01/2009	US20090247741 Process for the production of multiple cross-linked hyaluronic acid derivatives
10/01/2009	US20090247640 Antimicrobials having polyquaternary ammoniums and alcohol-bearing amidoamines and methods for their use
10/01/2009	US20090247638 Pharmaceutical use of cox-2-inhibitors in angiogenesis-mediated ocular disorders
10/01/2009	US20090247613 Chemically synthesized nucleic acid molecule with a pyrimidine modification; cancer, ocular disease, and other proliferative disorders; neovascularization, diabetic retinopathy, restenosis and polycystic kidney disease
10/01/2009	US20090247606 RNA Interference Mediated Inhibition of Adenosine A1 Receptor (ADORA1) Gene Expression Using Short Interfering Nucleic Acid (siNA)
10/01/2009	US20090247604 RNAi Therapeutics for Treatment of Eye Neovascularization Diseases
10/01/2009	US20090247594 Therapeutic compounds
10/01/2009	US20090247552 Aqueous liquid preparation containing amide compound
10/01/2009	US20090247543 Gatifloxacin-containing aqueous liquid preparation
10/01/2009	US20090247483 Method for Treatment of Macular Degeneration
10/01/2009	US20090247466 Neuroprotective integrin-binding peptide and angiopoietin-1 treatments
10/01/2009	US20090246201 Substances
10/01/2009	US20090246133 Methods and compositions related to internalizing rgd peptides
10/01/2009	CA2722618A1 Method of treating degenerative diseases
10/01/2009	CA2719453A1 Methods for improving lid margin and tear film function and treatment of lid margin disease using tetracycline family antibiotics
09/2009
09/30/2009	EP2105504A2 Genes and proteins, and their use
09/30/2009	EP2105141A1 Short bioactive peptides and methods for their use
09/30/2009	EP2105136A2 Pharmaceutical compositions for treating cancer
09/30/2009	EP2105135A2 Pharmaceutical compositions for treating cancer
09/30/2009	CN101544696A Compound containing pigment epidermal derived factors and preparation method and application thereof
09/30/2009	CN101543509A Ophthalmic gel containing chondroitin sulfate and method for preparing same
09/30/2009	CN101543507A Immunostimulatory nucleic acids
09/29/2009	US7595341 Analogues of lipid mediators derived from ω-3 PUFAs and methods of use
09/29/2009	US7595336 Isatine derivatives with neurotrophic activity
09/29/2009	US7595051 Methods of treating neovascular glaucoma, macular degeneration and capillary proliferation with alphavbeta3-specific antibodies
09/29/2009	CA2457944C Polycyclic guanine phosphodiesterase v inhibitors
09/29/2009	CA2434009C Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy
09/29/2009	CA2414586C Agent for therapeutic treatment of optic nerve diseases and the like
09/29/2009	CA2391085C Bis-basic compounds as tryptase inhibitors, processes for preparing them and their use as phamaceutical compositions
09/29/2009	CA2383983C Substituted indolealkanoic acids
09/29/2009	CA2310661C Ep2-receptor agonists as neuroprotective agents for the eye
09/24/2009	WO2009117465A1 Substituted gamma lactams as prostaglandin ep2 agonists
09/24/2009	WO2009117365A2 Vaccine compositons for inducing immune responses against components of drusen
09/24/2009	WO2009117242A2 Aqueous pharmaceutical compositions containing borate-polyol complexes
09/24/2009	WO2009116529A1 Polypeptide and pharmaceutical composition containing the polypeptide

1 ... 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 ... 531